About: Second-line irinotecan after cisplatin, fluoropyrimidin and docetaxel for chemotherapy of metastatic gastric cancer

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Second-line irinotecan after cisplatin, fluoropyrimidin and docetaxel for chemotherapy of metastatic gastric cancer Goto Sponge NotDistinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

scientific article published on 01 January 2012

Attributes	Values
rdf:type	Item
description	wetenschappelijk artikel (nl) научна статия (bg) наукова стаття, опублікована в січні 2012 (uk) im Jahr 2012 veröffentlichter wissenschaftlicher Artikel (de) artículu científicu espublizáu en xineru de 2012 (ast) artikull shkencor i botuar më 01 janar 2012 (sq) scientific article published on 01 January 2012 (en)
publication date	wds:Q84910499-194D058B-87B8-4214-953F-3B588E20224E
publication date	2012-01-01 00:00:00Z (xsd:dateTime)
author name string	wds:Q84910499-013894A2-ED30-4479-B680-4D7D68B5D073 wds:Q84910499-1D0230DF-0960-4B59-A583-EB3D6DF421C3 wds:Q84910499-47929577-57D0-4B99-BF5F-860C950A5DD6 wds:Q84910499-78525609-3F7C-4557-98E5-0C8B6D473B89 wds:Q84910499-8641EFC0-03DA-4A8E-83DB-E59D7FE13630 wds:Q84910499-A5681822-F6DC-457F-A5BA-6C84B812CB5D
author name string	Alper Can Ahmet Dirican Murat Akyol Ibrahim Vedat Bayoglu Isil Somali Murat Medeni
rdfs:label	Second-line irinotecan after cisplatin, fluoropyrimidin and docetaxel for chemotherapy of metastatic gastric cancer (en) Second-line irinotecan after cisplatin, fluoropyrimidin and docetaxel for chemotherapy of metastatic gastric cancer (nl) Second-line irinotecan after cisplatin, fluoropyrimidin and docetaxel for chemotherapy of metastatic gastric cancer (sq)
skos:prefLabel	Second-line irinotecan after cisplatin, fluoropyrimidin and docetaxel for chemotherapy of metastatic gastric cancer (en) Second-line irinotecan after cisplatin, fluoropyrimidin and docetaxel for chemotherapy of metastatic gastric cancer (nl) Second-line irinotecan after cisplatin, fluoropyrimidin and docetaxel for chemotherapy of metastatic gastric cancer (sq)
name	Second-line irinotecan after cisplatin, fluoropyrimidin and docetaxel for chemotherapy of metastatic gastric cancer (en) Second-line irinotecan after cisplatin, fluoropyrimidin and docetaxel for chemotherapy of metastatic gastric cancer (nl) Second-line irinotecan after cisplatin, fluoropyrimidin and docetaxel for chemotherapy of metastatic gastric cancer (sq)
author	wds:Q84910499-88F1FDCE-B04A-4B63-97D8-FF4CB6E10E72 wds:Q84910499-939422B2-109C-46C9-B426-11CC5C37B740 wds:Q84910499-D31DBF44-ADFC-4809-831B-31BFA9C89E4E wds:Q84910499-E742A5AE-27B6-4C02-97AF-1564004B12D8
author	Cigdem Erten Yuksel Kucukzeybek Mustafa Oktay Tarhan Lutfiye Demir
title	wds:Q84910499-91309977-07C5-4E22-914E-C102D8CBEABA
title	Second-line irinotecan after cisplatin, fluoropyrimidin and docetaxel for chemotherapy of metastatic gastric cancer (en)
page(s)	wds:Q84910499-5EEABB1C-FD91-4386-B44F-AD7EFC3EE13A
page(s)	2771-2774
instance of	wds:Q84910499-FED4B3E2-3A80-4D1D-A0A7-9B951AB43414
instance of	scholarly article
main subject	wds:Q84910499-510D5FB3-4900-4250-A530-A8B70902638D wds:Q84910499-5C2E7489-597D-4EBC-9DA8-2360ED4A0319 wds:Q84910499-B78E0870-3BF8-4FDD-A6B7-BDF8C6186383
main subject	irinotecan wd:Q420436 cisplatin
PubMed ID	wds:Q84910499-567F7BE9-25F2-4460-8583-C0E71889A0F0
PubMed ID	http://rdf.ncbi.nlm.nih.gov/pubchem/reference/22938457
PubMed ID	22938457
published in	wds:Q84910499-02B8A403-C79B-40A7-9971-1EA1F5A82C79
published in	Asian Pacific Journal of Cancer Prevention
issue	wds:Q84910499-E11937EB-FC27-4191-82F2-B9269FFF349C
volume	wds:Q84910499-77282EC9-4FDF-4EE4-AD31-DBC1734FE6C8
issue	6
volume	13
DOI	wds:Q84910499-0B395AE2-E50A-43F1-A88F-9F57DEAC5EF8
DOI	http://dx.doi.org/10.7314/APJCP.2012.13.6.2771
DOI	10.7314/APJCP.2012.13.6.2771
is about of	https://www.wikidata.org/wiki/Special:EntityData/Q84910499
is cites work of	Biomarker-Driven Therapy in Metastatic Gastric and Esophageal Cancer: Real-Life Clinical Experience. Safety and continuity of second- and third-line therapy with paclitaxel or irinotecan for advanced and recurrent gastric cancer
is cites work of	wds:Q49898050-CFA6089D-DDF0-4D6F-BB93-23479CA8BD64 wds:Q38956887-A1159F76-C889-435D-95FD-0186A6D2AB98

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 183 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2025 OpenLink Software